CTIS2023-510280-35-00招募中1 期
Effective strategy of withdrawal of pharmacological treatment of urinary incontinence in children (StayDry) - StayDry-2023
Region Midtjylland0 个研究点目标入组 216 人开始时间: 2024年1月9日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 216
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 年龄范围
- 0 至 17（—）
- 性别
- All
入选标准
- •The participants custody holder(s) must voluntarily sign and date an informed consent prior to initiation any study specific procedures., Age 5 to 14 years (inclusive) at the time of signing the consent., Diagnose with urinary incontinence as per ICCS criteria., Pharmacological treatment with solifenacin and/or mirabegron., Continence has been achieved on pharmacological therapy with solifenacin and/or mirabegron., Previously withdrawal attempts are accepted., Continence remained on the same dosage of medication for a minimum of three months.
排除标准
- •Neurogenic detrusor overactivity (neurogenic bladder)
研究者
相似试验
进行中（未招募）
4 期
Strategy for Withdrawal of Pharmacological Treatment for Urinary Incontinence in Children (StayDry)Urinary Incontinence in ChildrenNCT06465576University of Aarhus216
招募中
不适用
Optimal strategy for stopping medication for chronic functional constipation in children: Randomized controlled multicenter studyKCT0006286Hallym University Medical Center120
招募中
1 期
Withdrawal of Pharmacological Treatment in Patients Responding to Cardiac Resynchronization Therapy: (REMOVE)MedDRA version: 20.0Level: LLTClassification code: 10019279Term: Heart failure Class: 10007541Heart FailureCTIS2023-504946-70-00Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia60
进行中（未招募）
1 期
Withdrawal of pharmacological treatment in patients responding to cardiac resynchronization therapy: Open and randomized studyHeart failureEUCTR2021-001327-41-ESFundación para la formación e investigación sanitarias de la Región de Murcia60
尚未招募
Unknown
Prevention of medication errors in emergency settings.CTRI/2024/02/062206I